Cdc42 Effector Protein 2 (XCEP2) is required for normal gastrulation and contributes to cellular adhesion in Xenopus laevis by Nelson, Karen K & Nelson, Richard W
BioMed  Central
Page 1 of 16
(page number not for citation purposes)
BMC Developmental Biology
Open Access Research article
Cdc42 Effector Protein 2 (XCEP2) is required for normal 
gastrulation and contributes to cellular adhesion in Xenopus laevis
Karen K Nelson and Richard W Nelson*
Address: Biology Department, Wabash College, 301 W. Wabash Ave., Crawfordsville, IN 47933, USA
Email: Karen K Nelson - nelsonk@wabash.edu; Richard W Nelson* - nelsonr@wabash.edu
* Corresponding author    
Abstract
Background: Rho GTPases and their downstream effector proteins regulate a diverse array of
cellular processes during embryonic development, including reorganization of cytoskeletal
architecture, cell adhesion, and transcription. Changes in the activation state of Rho GTPases are
converted into changes in cellular behavior by a diversity of effector proteins, which are activated
in response to changes in the GTP binding state of Rho GTPases. In this study we characterize the
expression and function of one such effector, XCEP2, that is present during gastrulation stages in
Xenopus laevis.
Results: In a search for genes whose expression is regulated during early stages of embryonic
development in Xenopus laevis, a gene encoding a Rho GTPase effector protein (Xenopus Cdc42
effector protein 2, or XCEP2) was isolated, and found to be highly homologous, but not identical,
to a Xenopus sequence previously submitted to the Genbank database. These two gene sequences
are likely pseudoalleles. XCEP2 mRNA is expressed at constant levels until mid- to late- gastrula
stages, and then strongly down-regulated at late gastrula/early neurula stages. Injection of antisense
morpholino oligonucleotides directed at one or both pseudoalleles resulted in a significant delay in
blastopore closure and interfered with normal embryonic elongation, suggesting a role for XCEP2
in regulating gastrulation movements. The morpholino antisense effect could be rescued by co-
injection with a morpholino-insensitive version of the XCEP2 mRNA. Antisense morpholino
oligonucleotides were found to have no effect on mesodermal induction, suggesting that the
observed effects were due to changes in the behavior of involuting cells, rather than alterations in
their identity. XCEP2 antisense morpholino oligonucleotides were also observed to cause
complete disaggregation of cells composing animal cap explants, suggesting a specific role of XCEP2
in maintenance or regulation of cell-cell adhesion in early embryos. This loss of cell adhesion could
be rescued by co-injection with a morpholino-insensitive version of the XCEP2 mRNA.
Conclusions: XCEP2 appears to be an essential component in the early developmental program
in Xenopus laevis. XCEP2 is involved in maintenance of cell-cell adhesion, and as such may constitute
a regulatory component that could help to balance the need for tissue integrity and plasticity during
the dynamic cellular rearrangements of gastrulation.
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Background
Vertebrate gastrulation depends upon exquisite regulation
of diverse morphogenetic processes including changes in
cell shape, cellular adhesion and migration. For example,
in Xenopus laevis coordinated changes in cell shape and
motility guide the initial formation of the dorsal lip, the
initial site of mesodermal involution [1,2]. Later, the com-
pletion of involution of prospective mesodermal cells is
strongly influenced by biomechanical forces generated by
convergent extension of dorsal mesodermal cells [3]. Con-
vergent extension involves mediolateral elongation of
trunk mesoderm cells, followed by medially-converging
intercalation. While convergent extension of dorsal meso-
derm is a major driving force for the extension and com-
pletion of involution movements, epiboly of the non-
involuting ectoderm (driven by radial intercalation of
cells of the blastocoel roof) is also necessary for efficient
gastrulation [4]. The coordinated changes in cell shape
and cell migration associated with gastrulation are influ-
enced by diverse processes, including large-scale remode-
ling of cytoskeletal architecture and precise modulation of
cell-cell and cell-matrix associations.
The molecular basis for initiating and regulating the com-
plex cellular movements of vertebrate gastrulation is only
beginning to be discerned. Recent work has shown Wnt
proteins as key upstream regulators in gastrulation move-
ments. In Xenopus laevis and zebrafish, non-canonical Wnt
signaling on the dorsal side of developing embryos
directly initiates the cellular rearrangements and migra-
tion that contribute to convergent extension of involuting
mesoderm [5,6]. Other Wnt-mediated signals activate a
distinct protein kinase C-dependent signaling pathway,
which appears to affect Cdc42 signaling and to provide
cues that maintain tissue separation during gastrulation
[7,8]. Inactivation of this PKC-dependent pathway causes
ineffective separation of involuting mesoderm from over-
lying ectoderm in Xenopus, resulting in severe gastrulation
defects [8]. As with the planar cell polarity (PCP) pathway
in Drosophila [9], vertebrate Wnt signals during gastrula-
tion can involve signaling through the strabismus and
JNK (JUN N-terminal Kinase) proteins [10,11], and affect
cellular morphology and migratory behaviors through the
activities of a diversity of Rho family GTPases [10,12-14].
Experiments perturbing the activity of Rho GTPases have
suggested important regulatory roles for these proteins
during gastrulation in Xenopus [7,10,12,14]. Upon activa-
tion, Rho GTPases are known to interact with a variety of
downstream effector proteins which in turn mediate
changes in actin and microtubule cytoskeletal architecture
[15], cell adhesion [16], cell migratory behaviours [17],
vesicular transport [18] and signalling [19-21]. Regulation
of the coordinated cellular and tissue level processes
involved in gastrulation appears to involve multiple Rho
GTPases (including Rho, Rac and Cdc42) and multiple
downstream effector proteins. However, we are only cur-
rently beginning to discern the identities and functions of
the repertoire of effector proteins that specifically relay
Rho GTPase signals involved in the initiation and coordi-
nation of gastrulation movements.
Regulation of cell-cell adhesion is thought to be of partic-
ular importance during gastrulation movements in Xeno-
pus, when the integrity of the elongating mesodermal
sheet must be maintained at the same time that major cel-
lular rearrangements are occuring. Downregulation of C-
cadherin-mediated cellular adhesion has been observed
to correlate with convergent extension movements of
mesodermal cells [22]. This change in C-cadherin medi-
ated adhesion between blastomeres occurs with no detect-
able change in cell surface expression of the C-cadherin
protein. While the precise mechanism of regulation in this
developmental context remains unclear, it is known that
lateral clustering of cadherins (mediated through interac-
tions between cytoplasmic tails of cadherin proteins) is
capable of strengthening adhesive function [23]. In addi-
tion, it is also known that Rho GTPases can act through
the IQGAP protein to regulate cadherin-mediated adhe-
sion [24-27]. Recent chararacterization of the develop-
mental pattern of IQGAP expression in Xenopus embryos
suggests that analogous upstream regulatory mechanisms
may operate during Xenopus gastrulation [28].
In this study, the embryonic expression pattern and func-
tion of a Xenopus gene encoding a member of the recently
characterized CEP/BORG family of RhoGTPase effector
proteins [29,30] is explored. These proteins have been
shown to have distinct effects on cytoskeletal architecture,
cellular morphology, adhesion and migratory behaviours
[29,30], and have also been shown to regulate septin
function during cytokinesis [31,32].
Xenopus Cdc42 Effector Protein 2, hereafter referred to as
XCEP2, is shown here to be developmentally regulated
during early embryonic stages, with diffuse expression of
mRNA in the animal region that diminishes during late
gastrula to neurula stages. Experiments employing mor-
pholino-mediated inhibition of translation suggest that
expression of this protein is essential for normal gastrula-
tion movements, and that its activity is required for main-
tenance of cell-cell adhesion between blastomeres of
animal cap explants.
Results
Xenopus laevis cdc42 effector protein 2 (XCEP2) is 
present in two allelic forms, and its expression is 
developmentally regulated during early embryogenesis
A differential display approach was employed to reveal
genes that are developmentally regulated during theBMC Developmental Biology 2004, 4:13 http://www.biomedcentral.com/1471-213X/4/13
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XCEP2 Nucleic Acid and Amino Acid Sequences Figure 1
XCEP2 Nucleic Acid and Amino Acid Sequences. (A) The nucleic acid sequence of the XCEP2A cDNA is shown. 
Sequences encoding the start methionine (green), the stop codon (red) are indicated. The protein coding region is shown in 
blue. (B) Amino acid sequences of the two Xenopus pseudoalleles of CEP2, along with the mammalian (human) sequence, are 
shown. Asterisks indicate highly conserved residues within the CRIB domain (black asterisks, lines), the CI domain (red aster-
isks, lines) and the CII domain (blue asterisks, lines) in the CEP-2 protein. Dark gray shading indicate residues conserved in all 
three species; light gray areas indicate residues that are conserved between two of the three species listed. Vertically oriented 
pairs of dots (:) indicate positions where amino acid identity is conserved in all three sequences.BMC Developmental Biology 2004, 4:13 http://www.biomedcentral.com/1471-213X/4/13
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transition from blastula to neurula. This screen allowed
for the isolation of numerous cDNA fragments corre-
sponding to differentially regulated mRNAs present in the
Xenopus embryo. The sequence of one of these fragments
was found to be highly homologous to the translational
start site region of database cDNA sequences encoding
Cdc42 effector protein 2. A full length cDNA correspond-
ing to our isolated fragment was amplified using 3' RACE
PCR, cloned and sequenced. An alignment of the pre-
dicted amino acid sequence for our isolated full length
cDNA sequence with human [29] and Xenopus (accession
number BC045241) CEP2/BORG1 genes from Genbank
revealed significant homology (see Figure 1), particularly
within and immediately surrounding the conserved CRIB,
CI and CII domains [29,30,33]. When comparing the two
Xenopus  sequences, there were a significant number of
positions where the amino acid sequence derived from
our isolated cDNA sequence differed from that found in
the Genbank sequence (15% of the amino acids were
non-identical). These differences were found to occur
almost exclusively in regions of the protein outside the
three conserved domains (CRIB, CI and CII) that define
the CEP family of effector proteins. Given the allotetra-
ploid genetic ancestry of Xenopus laevis, and the degree of
similarity between the sequences, it is likely that these two
sequences constitute pseudoalleles of the same gene. We
choose to refer to our isolated pseudoallele as XCEP2A
and the database allele as XCEP2B.
Semi-quantitative RT-PCR was conducted on staged RNA
samples using primers specific to the 5' untranslated
sequence of the isolated XCEP2A cDNA. This analysis
revealed the presence of maternally-derived XCEP2A
mRNA prior to the onset of zygotic transcription (embry-
onic stage 7.5), maintenance of this expression level
through mid-gastrula stages, with a downregulation of
mRNA expression starting at stage 10.5 and becoming
more marked by stage 12.5 (see Figure 2). RT-PCR analy-
sis of the expression of the other pseudoallele (XCEP2B)
revealed an expression pattern similar to XCEP2A (see Fig-
ure 2, lower panel), with an almost complete loss of
detectable expression by stage 12.5. Both patterns corre-
spond to that observed for the amplified fragments origi-
nally isolated from the original differential display gels
(data not shown). In situ hybridization revealed that
XCEP2A mRNA (corresponding to our isolated pseudoal-
lele) is distributed uniformly over the animal hemisphere
of the embryo at blastula and early gastrula stages (see Fig-
ure 3A and 3B), with an animal to vegetal gradient in
staining evident (Figures 3B and 3C). Over time, there is a
diminution of the intensity but no change in the general
expression pattern as the embryo transitions from blastula
to gastrula stages (data not shown).
Morpholino oligonucleotides directed against XCEP2 
cause gastrulation defects
In order to assess the functional role of XCEP2 in early
embryogenesis, microinjections were conducted with
antisense morpholino oligonucleotides, MO1 and MO2
directed to the translational start site region of one or both
of the two XCEP2 pseudoalleles. MO1 is targetted to
XCEP2A, and MO2 is targetted to the XCEP2B sequence
found in the Genbank database. For this experiment, a
total of 100 ng of morpholino oligonucleotide was
injected into the animal region of one-cell embryos. At
time points just prior to blastopore closure (~embryonic
stage 12), MO1 antisense oligonucleotides pseudoalleles
elicited significant gastrulation delay as compared to an
identical dose of control morpholino oligonucleotide
(See Figure 4A). A comparison of the effects of each mor-
pholino, and the combined effects of co-injection of both
morpholinos is shown in Figure 4B. The severity of gastru-
lation delay was quantified at late gastrulation by compar-
ing the ratio of blastopore diameter to embryo diameter
in antisense-injected, control injected and non-injected
embryos. The mean ratio, and the distribution of ratios
differed significantly between control injected and anti-
sense morpholino injected groups (See Figure 4B and 4C).
MO2 was slightly less effective than MO1 in producing
gastrulation delay. Small differences between the effects of
the various injection conditions suggest that either the
MO2 morpholino is less efficient at translational inhibi-
tion, or that the pseudoallele targeted by MO2 may be
expressed at comparatively lower levels. The combined
Temporal regulation of XCEP2 during pre-neurula stages of  embryonic development Figure 2
Temporal regulation of XCEP2 during pre-neurula 
stages of embryonic development. Semi-quantitative 
RT-PCR was conducted on equivalent amounts of RNA 
derived from the indicated developmental stages. XCEP2A 
was amplified using XCEP2A forward and reverse primers 
(see Methods). Ornithine Decarboxylase (ODC) serves as a 
loading control (middle panel). RT-PCR amplification to 
reveal expression of the alternative pseudoallele (XCEP2B), 
using XCEP2B forward and reverse primers, is shown in the 
lower panel.BMC Developmental Biology 2004, 4:13 http://www.biomedcentral.com/1471-213X/4/13
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MO1+MO2 condition did not produce more severe
defects than the individual morpholino injections, per-
haps because the dose of each morpholino in the com-
bined condition was half that in either of the single
morpholino conditions (all injections were 100 ng, the
combined condition included 50 ng of each mor-
pholino). Many of the more severely affected embryos at
this dose did not complete blastopore closure, and
Spatial Localization of XCEP2 mRNA Figure 3
Spatial Localization of XCEP2 mRNA. (A) Animal pole view in situ hybridization of embryos fixed at late blastula stage 
with digoxygenin-labeled antisense XCEP2A antisense probe exhibit diffuse staining across the animal region of the embryo 
(right). An XCEP2A sense probe served as a negative control, and showed minimal background staining (left). (B) A blastula 
stage embryo, cut to reveal a cross-section, reveals the animal/vegetal gradient of antisense XCEP2 probe. The blastocoel cav-
ity is visible in the upper portion of this embryo. (C) A side view of an antisense XCEP2A probed embryo, revealing an animal 
(top) to vegetal (bottom) gradient of staining.BMC Developmental Biology 2004, 4:13 http://www.biomedcentral.com/1471-213X/4/13
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Effects of antisense XCEP2 morpholino oligonucleotide on gastrulation Figure 4
Effects of antisense XCEP2 morpholino oligonucleotide on gastrulation. (A) Injected embryos received 100 ng of 
morpholino, delivered to the animal region of 1-cell embryos. Typical gastrula stage embryos for each of three experimental 
conditions (non-injected, control morpholino and MO1 antisense injected) are shown. (B) The distribution of blastopore-to-
embryo diameter ratios for each experimental condition. 18–20 embryos were assessed for each condition. In the combined 
"MO1+MO2" condition, 50 ng of each morpholino were co-injected. (C) Average blastopore to embryo diameter ratios for 
each of the control and experimental conditions, +/- 1SEM, are shown. (D) Effects of antisense morpholinos on post-neurula-
tion embryonic development are shown. Antisense XCEP2-injected embryos exhibit dose-dependent abnormalities suggestive 
of gastrulation and/or convergence extension defects. Representative viable embryos, at Stage 26–27, from each control and 
experimental condition are shown. Several embryos in the MO1 treated groups exhibited varying degrees of spina bifida. 
Embryonic viability for the water, control morpholino, and the three doses of antisense XCEP2 morpholino (75 ng, 95 ng and 
115 ng) were 90%, 90%, 81%, 63%, and 26%, respectively (20–30 embryos injected for each condition).BMC Developmental Biology 2004, 4:13 http://www.biomedcentral.com/1471-213X/4/13
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showed lethal defects that precluded normal neurulation.
Embryos that survived treatments of between 75 and 115
ng of antisense morpholino (MO1) were found to have
phenotypes consistent with gastrulation defects, includ-
ing significant shortening of the AP axis and multiple
instances of spina bifida (see Figure 4D). The phenotypes
we observe share significant similarity to defects caused by
specific inhibition of convergent extension in mesoderm
[34]. At a higher dose (100 ng injected into each blast-
omere of 2-cell stage embryos, 200 ng total injection),
embryonic lethality was observed consistently in practi-
cally all treated embryos prior to neurulation (see Figure
8A, lower panel).
The antisense morpholino oligonucleotides used in these
studies were found to elicit specific translational inhibi-
tion of XCEP2. Injection of antisense morpholino against
our isolated pseudoallele resulted in largescale inhibition
of translation of a myc-tagged fusion protein from co-
injected mRNA (see Figure 5B). A modified mRNA
(XCEP2A*-myc) encoding a C-terminal myc tagged
XCEP2A fusion protein, with seven point mutations in the
5' untranslated region and at the 3rd base of selected
codons in the translated region (see Figure 5A), was found
to be insensitive to inhibition by antisense morpholino
oligonucleotide MO1 (See Figure 5B), demonstrating
sequence specificity of the translational inhibition effect.
XCEP2A* myc migrates as a doublet, which probably
arises due to inefficient translational initiation at the true
start codon of the mutated mRNA and some initiation at
the second AUG codon, encoding methionine at position
29 (see Figure 1B). While MO1 does not inhibit transla-
tion from the multiply mutated XCEP2A* myc mRNA, we
did find that MO2, which is designed to be complemen-
tary to the database pseudoallele, was capable of signifi-
cantly reducing translation from mRNA corresponding to
our isolated pseudoallele (XCEP2A-myc). This suggests
that under these conditions, the two-nucleotide mismatch
between MO2 and our XCEP2A-myc mRNA does not pre-
clude translational inhibition (to compare sequences, see
Methods, "Morpholino Oligonucleotides"). Given this
observation, it is possible that injection of either antisense
XCEP2 morpholino significantly reduces the endogenous
expression of both pseudoalleles. In addition to the dos-
age issue in the combined condition (noted above), cross-
inhibition of this type could contribute to the observed
lack of additive effects in the combined MO1 + MO2
condition.
The blastopore closure delay phenotype observed in anti-
sense morpholino injected embryos could be completely
rescued by co-injection with 0.7 ng of the
XCEP2A*mRNA, which is insensitive to translational
inhibition (see Figure 6). This result suggests that the
observed effects of antisense morpholino oligonucle-
otides on gastrulation are not due to inhibition of a non-
XCEP2 gene product, or to non-specific toxicity of the
antisense oligonucleotides. This observation strongly sug-
gests that the observed effects of the antisense oligonucle-
otides on embryogenesis are attributable to a specific
knockdown of translation of the endogenous XCEP2
mRNA, and a concomitant reduction in XCEP2 protein.
In contrast to the morpholino knockdown effects, overex-
pression of XCEP2 in embryos by injection of up to 1 ng
XCEP2 mRNA was found to result in no detectable abnor-
malities in embryonic development (data not shown).
The absence of effects may not be unexpected, given cur-
rent models of RhoGTPase effector protein activation.
RhoGTPase effector proteins are activated by direct bind-
ing to GTP-bound RhoGTPases. As such, the number of
activated RhoGTPase molecules may constrain the
number of effector proteins bound and activated, regard-
less of the heightened expression levels of the effector
protein.
XCEP2 morpholinos do not interfere with mesoderm 
induction
The observed effects of antisense XCEP2 morpholinos in
Xenopus embryos suggests that XCEP2 may play a direct
role in directing the morphogenetic movements of gastru-
lation. This interpretation would be consistent with the
limited characterization that have thus far been conducted
on functional properties of this class of proteins [29,30].
However, it is also conceivable that XCEP2 antisense mor-
pholinos may indirectly inhibit gastrulation by interfering
with mesodermal induction. In order to assess this possi-
bility, the level of expression of the pan-mesodermal
marker, brachyury, and the dorsal mesodermal marker,
goosecoid, was assessed in control and antisense mor-
pholino injected embryos at gastrula stage using semi-
quantitative RT-PCR (see Figure 7). Expression of meso-
dermal markers was similar in non-injected, control mor-
pholino injected and antisense XCEP2 injected embryos,
suggesting that it is the behavior of mesodermal cells dur-
ing gastrulation (rather then the presence or absence of
mesodermal cells) that is affected by XCEP2 antisense
morpholino oligonucleotides.
XCEP2 morpholinos Interfere with cell-cell adhesion in 
animal cap explants
In order to assess the mechanism by which XCEP2 influ-
ences gastrulation, the effects of XCEP2 morpholinos on
cultured animal cap explants were evaluated. While the
initial intent of these experiments was to discern whether
XCEP2 morpholinos prevented normal activin-induced
convergent extension of animal caps, it soon became clear
that morpholino-treated explants had a more fundamen-
tal deficiency. Within a 24 hour period, animal cap
explants derived from XCEP2 antisense morpholinoBMC Developmental Biology 2004, 4:13 http://www.biomedcentral.com/1471-213X/4/13
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(MO1) -injected embryos were found to completely lose
their integrity (see Figure 8A, upper right panel),
collapsing into piles of dissociated cells. This contrasts
with control injected and non-injected caps, which
remained tightly associated at 24 hours (see Figure 8A,
upper left panels). This result was evident with or without
Antisense XCEP2 morpholino oligonucleotides specifically inhibit translation from XCEP2 mRNA Figure 5
Antisense XCEP2 morpholino oligonucleotides specifically inhibit translation from XCEP2 mRNA. (A) Sche-
matic diagram indicating mutations (designated by asterisks) in the morpholino target site of XCEP2*-myc mRNA that would 
be expected to inhibit strong interactions with the antisense XCEP2 morpholino (MO1). (B) 0.7 ng of mRNA encoding myc-
tagged XCEP2 (either the normal XCEP2-myc or the mutated XCEP2*-myc) was injected alone or in combination with 80 ng 
of antisense XCEP2 morpholino oligonucleotide (MO1) into the animal pole of 1-cell embryos. XCEP2 protein was detected in 
embryo extracts (prepared at stage 8.5–9) by Western Blotting using anti-myc monoclonal antibody 9E10 (upper panels). 
Equivalency in protein loads in the Western Blot lanes are indicated by the similarity in staining intensity of protein bands in the 
corresponding SYPRO Ruby-stained gels in the lower panels.BMC Developmental Biology 2004, 4:13 http://www.biomedcentral.com/1471-213X/4/13
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Rescue of the antisense XCEP2 morpholino phenotype by XCEP2 mRNA co-injection Figure 6
Rescue of the antisense XCEP2 morpholino phenotype by XCEP2 mRNA co-injection. Injected embryos received 
100 ng of morpholino oligonuceotide in the animal region of both blastomeres in two-cell stage embryos. MO1 and MO2 oli-
gonucleotides were mixed at a molar ratio of 3:1, respectively. 20–30 embryos were assessed for each condition. (A) The dis-
tributions of blastopore to embryo diameters for the indicated experimental conditions are shown. The rescuing XCEP2 
mRNA (XCEP*-myc) sequence was altered such that antisense morpholino oligonucleotides would be expected to bind ineffi-
ciently. (B) Average blastopore to embryo diameter ratios, +/- 2 SEM, are indicated for each experimental condition.BMC Developmental Biology 2004, 4:13 http://www.biomedcentral.com/1471-213X/4/13
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activin treatment (data for activin treated caps is not
shown). The observed defect in XCEP2 MO1 treated caps
suggested a loss of cell-cell adhesion, as cells of disinte-
grated explants appeared to be completely dissociated,
with few if any adherent clusters of cells. The observed loss
of integrity followed a reproducible pattern. At approxi-
mately 18 hours after explantation, dissociated cells from
the interior of the explant could often be observed dis-
charging from the healed wound site (or, in some cases, at
other localized sites), causing the explants to become pro-
gressively reduced in size. The cells of the outer pigmented
epithelium of the explant remained adherent until the lat-
est stages of the 24 hour time course, by which time they
often also dissociated.
The animal cap dissociation caused by the MO1 mor-
pholino could be largely rescued by co-injection with a
XCEP2*myc mRNA (see Figure 8B), which has modifica-
tions that make it insensitive to translational inhibition
by our morpholinos (see Figure 5B). This suggests that the
dissociation observed is not a non-specific toxicity or
cross-inhibition effect. XCEP2*myc mRNA rescued
explants showed little difference from non-injected con-
trols at and beyond the 24 hour time point.
Discussion
The Rho GTPases and their associated effector proteins are
known to play diverse roles in the regulation of cytoskele-
tal remodelling, cellular adhesion and cell motility. The
complex morphogenetic movements associated with gas-
trulation in Xenopus, including changes in the morphol-
ogy and polarity of mesodermal cells, and their later
mesolateral intercalation of these cells during convergent
extension, are now known to be dependent upon RhoGT-
Pase functions [5,12,14] (for review, see [35,36]). Cur-
rently, however, there is little known regarding the
identity or role of specific effector proteins that are uti-
lized to convert changes in the GTP binding state of
RhoGTPases into gastrulation-associated changes in
cytoskeletal architecture, cell morphology, and cellular
adhesion and migration.
The data presented here indicate a role for the Xenopus
Cdc42 effector protein 2 (XCEP2) in gastrulation move-
ments. XCEP2 is a member of the recently characterized
CEP family of Rho GTPase effector proteins [29,30],
which include the previously characterized mouse pro-
tein, MSE55 [33]. Effector proteins of the CEP family
share a conserved expanded CRIB domain, which binds
Rho GTPases, and two other highly conserved protein
domains (CI and CII) [29,30]. By analogy to other Rho
GTPase effector proteins, it has been proposed that Cdc42
binding to the CRIB domain of CEP proteins leads to a
conformational change that exposes the previously inac-
cessible CI or CII domains (reviewed in [37]). The
exposed domains of the effector protein would then be
free to interact with downstream components of the
signaling/regulatory pathway. When overexpressed in cul-
tured cells, members of this family of effector protein
induce marked pseudopodial/ lamellipodial extensions,
membrane ruffling, alterations in actin and vinculin
organization, and a reduction of E-cadherin staining at
adherens junctions [29,30].
Consistent with a potential role for this class of proteins
in embryonic morphogenesis, we have shown that XCEP2
Antisense XCEP2 morpholino oligonucleotides do not inhibit mesodermal induction Figure 7
Antisense XCEP2 morpholino oligonucleotides do not inhibit mesodermal induction. Semiquantitative RT-PCR 
analysis was conducted on duplicate RNA samples using primers for Brachyury (a pan-mesodermal marker), goosecoid (a dor-
sal mesodermal marker) and ornithine decarboxylase ("ODC", used as loading control). For control and morpholino-injected 
conditions, 100 ng of morpholino oligonucleotide was injected into the animal region of 1-cell stage embryos.BMC Developmental Biology 2004, 4:13 http://www.biomedcentral.com/1471-213X/4/13
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expression is temporally regulated at gastrulation stages,
when major modulations of cellular morphology,
cytoskeletal organization, and cellular adhesion are occur-
ring. mRNA for XCEP2 is present prior to mid-blastula
transition, persists through mid gastrulation, and is
strongly down-regulated by the time the blastopore closes
and neurulation begins. This pattern would suggest that
XCEP2 protein would be present through the period when
Effects of antisense XCEP2 Morpholino oligonucleotides on animal cap explant cell adhesion Figure 8
Effects of antisense XCEP2 Morpholino oligonucleotides on animal cap explant cell adhesion. (A) 100 ng mor-
pholino oligonucleotide MO1 was injected into the animal region of each blastomere of 2-cell stage embryos. Animal cap 
explants from antisense MO1-injected embryos exhibited a marked loss of integrity (upper right panel) 24 hours after explan-
tation, as compared to animal caps from non-injected or control morpholino injected embryos (upper left panels). Effects of 
these treatments on whole sibling embryos at Stage 22–23 are shown in the lower panels. In (B), embryos were injected with 
75 ng of MO1 antisense morpholino in each blastomere at the 2-cell stage. Animal explants derived from non-injected embryos 
(left panel), MO1-injected embryos (middle panel), or embryos co-injected with 0.7 ng XCEP2*myc mRNA (right panel) are 
shown 24 hours after explantation.BMC Developmental Biology 2004, 4:13 http://www.biomedcentral.com/1471-213X/4/13
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active gastrulation movements are occurring. The diffuse
spatial pattern of mRNA and, presumably, protein expres-
sion of XCEP2 may suggest that XCEP2 functions broadly
in cells of the animal and equatorial regions. However,
the observed broad spatial distribution of XCEP2 mRNA
does not preclude the possibility that the XCEP2 protein
may be functionally activated or inactivated at discreet
times and locations during early embryonic development.
Furthermore, we show that antisense morpholino oligo-
nucleotides capable of blocking translation of the XCEP2
message interfere with Xenopus gastrulation, delay the clo-
sure of the blastopore and inhibit embryonic elongation.
The observed rescue with XCEP2 mRNA is strong evidence
for the specificity of the antisense morpholino effect.
These effects are not due to a loss of mesodermal induc-
tion, as brachyury and goosecoid expression do not
change in response to antisense XCEP2 morpholinos. This
is particularly relevant given recent reports demonstrating
a direct link between brachyury expression and control of
cellular migration [38].
The effects we report require relatively high, although not
unprecedented, doses of morpholino antisense oligonu-
cleotide. This dosage requirement may reflect the diffi-
culty inherent in morpholino-mediated translational
knockdown of maternally expressed genes. XCEP2 mRNA
and (presumably) XCEP2 protein are present prior to
midblastula transition. Given this situation, the timing
morpholino induced protein downregulation is depend-
ent both upon the effectiveness of translational blockade,
and the half life of the protein in the cytoplasm. In this
context, it may be essential to impose close to complete
translational inhibition in order to reduce protein levels
rapidly enough to affect early embryonic events, such as
gastrulation.
Clearly, specific probes to assess endogenous XCEP2 pro-
tein expression will be necessary for fuller characterization
of the role of this protein during gastrulation. For this rea-
son, antibodies are currently being raised against the
XCEP2 protein. These antibodies will be important in the
characterization of the developmental time course of
endogenous XCEP2 protein expression, assessment of the
subcellular localization of the XCEP2 protein, isolation of
potential XCEP2 binding partners, and in assessing and
further optimizing the extent of protein down-regulation
in morpholino injected embryos.
Currently, the specific mechanism by which XCEP2 exerts
its role in gastrulation is unknown. However, our prelim-
inary data suggest that XCEP2 may either contribute to a
required "ground state" of cellular adhesion or play a role
in modulations in the strength of cadherin-mediated cell-
cell adhesion that are known to occur during gastrulation
[22,39,40]. More detailed work will be necessary to clearly
distinguish between these possibilities.
In embryos Wnt-mediated signals have been shown to
activate Cdc42, a process that is required for normal gas-
trulation movements [7,12]. In future work, it will be
important to discern whether XCEP2 plays an important
role in transducing these upstream signals into changes in
cellular behaviour during gastrulation.
The known functional properties of the CEP class of effec-
tor proteins, and the characteristics of CRIB domain effec-
tor proteins in general, suggest some interesting
possibilities relating to the control of cell adhesion during
gastrulation. Consistent with the observed functions of
the XCEP2 homologs in cultured cells, XCEP2 in embryos
may impinge on regulatory circuits downstream of Cdc42
that control actin filament assembly, which in turn may
affect diverse cellular processes, including assembly of
adherens junctions. Alternatively, XCEP2 may more
directly impinge upon cadherin functional activity, per-
haps by influencing the association of IQGAP or other
molecules with cadherin complexes. In future studies, it
will also be important to establish whether embryonic
activation of whether there are links between Wnt-medi-
ated activation of Cdc42 and functional activation of
XCEP2 and to characterize the mechanism(s) by which
XCEP2 contributes to cell adhesion between cells of gas-
trulating embryos.
Conclusions
It has become clear in recent years that an integrated net-
work of signals involving Rho GTPase proteins and their
effector proteins help to control and regulate the diverse
and intricate morphogenetic processes that occur during
embryonic development. Less clear are the specific modes
of functional interaction between the multiple Rho
GTPases and the diversity of potential effector proteins.
We have shown that XCEP2 is one component in the com-
plex regulatory puzzle contributing to morphogenetic
processes during Xenopus gastrulation. For this reason it
will be interesting and important to discern further the
role of XCEP2, with regard both to its relationship to
intracellular signalling pathways and its effects on cellular
behavior during gastrulation.
Methods
Restriction fragment differential display primer and 
adaptor sequences
Adaptor 1-
5'-ATGAGTCCTGAC-3' (upper strand)
5'-PO4-CGGTCAGGACTCAT-3'(lower strand).BMC Developmental Biology 2004, 4:13 http://www.biomedcentral.com/1471-213X/4/13
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Adaptor 2 (the 3' phosphate group of the lower strand
inhibits DNA polymerase extension)-
5'-ACTGGTCTCGTAGACTGCGTACC-3'(upper strand)
5'-PO4-CGGGTACGCAGTC-PO43' (lower strand).
"Universal" RFDD-PCR primer (complementary to Adap-
tor 2)-
5'-ACTGGTCTCGTAGACTGC-3'
"Selection" Primer 4 (complementary to Adaptor 1, with
a 3-nucleotide 3' extension)
5'-ATGAGTCCTGACCGAAAG-3' (3-nucleotide extension
is underlined)
Primers used for construction of full-length XCEP2 cDNAs 
(sequences encoding start codon shown in bold, PCR-
induced mutation sites are underlined)
XCEP2 cDNA forward-
5'-ATTGCAAAGATGTCCGCCAAG-3'
XCEP2* cDNA forward-
5'-CGGGATCCTAGATGTCGGCGAAAGCGCCGATATAC-
CTAAAGAG AAG-3'
XCEP2 cDNA reverse-
5'-AACGTATCCCCTTCCCCA-3'
RT-PCR primer sequences
XCEP2A forward (complementary to 5' untranslated
region of the cDNA sequence)
5'-AACGTATCCCCTTCCCCA-3'
XCEP2A reverse (complementary to 5' untranslated
region of the cDNA sequence)
5'-AAAGAGAAGTAGCCGTAAAGGA-3'
XCEP2B forward
5'-GCCAAGGCCCCGATATAC-3'
XCEP2B reverse
5'-CCAATAGCAGGTAGGGAA-3'
Brachyury forward
5'-GGATCGTTATCACCTCTG-3'
Brachyury reverse
5'-GTGTAGTCTGTAGCAGCA-3'
Goosecoid forward
5'-ACAACTGGAAGCACTGGA-3'
Goosecoid reverse
5'-TCTTATTCCAGAGGAACC-3'
ODC forward-
5'-GTCAATGATGGAGTGTATG-3'
ODC reverse
5'-TCCATTCCGCTCTCCTGA-3'
Morpholino oligonucleotides
Antisense morpholino oligonucleotides, which specifi-
cally block translation of targeted mRNAs [41] were syn-
thesized by GeneTools, LLC (Philomath, OR) and were
designed to interact with both characterized pseudoalleles
of the XCEP2 gene. Antisense oligos were targeted to the
region upstream and downstream of the translational start
site of the XCEP2 mRNA. The target sequences that were
chosen were compared to the Genbank database to con-
firm that the XCEP2 antisense oligonucleotides would not
be expected to interfere with the expression of other
known gene products. The morpholino sequences utilized
in these studies were as follows, with morpholino
sequence complementary to the start codon of the cognate
mRNA shown in bold:
Antisense XCEP2 MO1 (specific to the XCEP2A, character-
ized in this study)-
5'-GGGCCTTGGCGGACATCTTTGCA-3'
Antisense XCEP2 MO2 (specific to XCEP2B, Xenopus Gen-
bank sequence accession # BC045241)-
5'-GGGCCTTGGCTGACATCTTTCCA-3'
Control Morpholino oligonucleotide
5'-CCTCTTACCTCAGTTACAATTTATA-3'BMC Developmental Biology 2004, 4:13 http://www.biomedcentral.com/1471-213X/4/13
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Restriction fragment differential display PCR, gene 
identification and isolation
Restriction Fragment Differential Display PCR (RFDD-
PCR) procedures were patterned closely after the commer-
cially available DisplayProfile kit from QBiogene
(Carlsbad, CA), with minor modifications. In this differ-
ential display procedure, Adaptors 1 and 2 (see RFDD-
PCR primer and adaptor sequences, above) are ligated to
restriction digested, double stranded cDNA. Amplifica-
tion of this cDNA is conducted with the "universal
primer", complementary to one of the adaptor sequences,
and one of 64 "selection" primers that bind largely to the
to the second adaptor sequence but have a 3-nucleotide 3'
extension that is complementary only to a subset of cDNA
inserts. An extension-inhibiting chemical modification of
the lower strand Adaptor 1, consisting of a 3' phosphate
group in our modified procedure, and the 3-nucleotide
extension of the selection primer largely restricts amplifi-
cation to cDNA fragments that have different adaptor
sequences ligated on opposite ends. Furthermore, any
particular selection primer will selectively amplify only a
subset of cDNA fragments (in theory, approximately 1/
64th of the total).
Total RNA from staged, duplicate batches of Xenopus laevis
embryos was purified using Trizol reagent (Invitrogen,
Carlsbad, CA). RNA from Xenopus laevis embryonic stages
7, 8.5, 9.5, 10.5 and 12.5 were prepared. First strand
cDNA was synthesized using oligo dT primer and Super-
script III reverse transcriptase (Invitrogen), followed by
second strand synthesis catalyzed by DNA polymerase I
(Roche, Indianapolis, IN). Double stranded cDNA was
purified using GeneClean silica resin (Qbiogene,
Carlsbad, CA), and then digested with TaqI restriction
enzyme (Roche, Indianapolis, IN). An annealed mix of
RFDD-PCR of Adaptor 1/Adaptor 2 oligonucleotides was
added, and ligated to the TaqI digested cDNA ends using
T4 DNA Ligase (Roche). Touchdown PCR using the uni-
versal RFDD-PCR primer, 35S-labelled dCTP, and "Selec-
tion" Primer 4 was conducted using Accuprime PCR mix
(Invitrogen), with the following cycling parameters:
Pre-dwell: 94°C 4 minutes
10 cycle touchdown PCR, with a 0.5 temperature decre-
ment each cycle:
94°C 30 seconds
60°C→ 55°C 30 seconds
72°C 1 minute
30 cycle standard amplification:
94°C 30 seconds
55°C 30 seconds
72°C 30 seconds
Post dwell: 72°C, 5 minutes
Samples were run on a standard 6% denaturing DNA
sequencing gel, and the gel was dried and subjected to
autoradiography. Bands showing differential expression
were excised from the gel and eluted by heating at 95°C
for 15 minutes. Eluted fragments were re-amplified with
30 cycles of standard PCR, using the original primers
(above). Direct cycle sequencing of isolated product
(Thermosequenase; United States Biochemical, Cleve-
land, OH) revealed that one of the fragments corre-
sponded to the 5' end (overlapping the translational start
site) of a Xenopus  homologue of the Cdc42 Effector
Protein 2, which we refer to as "XCEP2". The full length
cDNA was amplified using gene-specific primers and
poly-dT primers using standard 3' RACE procedures [42].
The sequence of the full-length cDNA was determined by
commercial automated sequencing (MWG Biotech, High
Point, NC).
Plasmid construction and RNA preparation
The RACE amplified full-length fragment isolated from
the RFDD-PCR procedure (see above) was cloned into the
pCR2.1 vector, using the pCR2.1 TA cloning kit (Invitro-
gen), and commercially sequenced (MWG Biotech). To
construct a vector encoding XCEP2A fused to a C-terminal
6xmyc tag, PCR was conducted using primers directed to
the 5' and 3' end of the XCEP2A cDNA sequence (XCEP2A
cDNA forward and XCEP2A cDNA reverse) with the
cloned, full length XCEP2A as template. The primers used
in this PCR mutated the normal stop codon and intro-
duced a BamHI and ClaI site at the 5' and 3' ends of the
amplified product, respectively. BamHI/ClaI digested full
length cDNA was directionally cloned in the sense orien-
tation into the corresponding into BamHI/ClaI digested
pCS2-myc vector, producing the plasmid pCS2-XCEP-
myc. In this context, the full length X-CEP2A cDNA
encodes a fusion protein with a C-terminal 6x myc tag. A
second construct, containing introduced mutations in the
XCEP2A antisense morpholino target region, was also
derived by PCR. To construct this vector, PCR was con-
ducted using XCEP2* forward and XCEP2 reverse primers
with the full-length XCEP2 DNA as template. XCEP2* for-
ward introduced multiple changes in the sequence of the
cDNA encoding the translational start site region (see Fig-
ure 5A). These changes do not change the predicted
amino acid sequence of the encoded protein, but would
be expected to significantly reduce or eliminate binding ofBMC Developmental Biology 2004, 4:13 http://www.biomedcentral.com/1471-213X/4/13
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the antisense morpholino oligonucleotides used in this
study.
For transcription of antisense probe for in situ hybridiza-
tion, the full length X-CEP2A cDNA was subcloned into
the pCS2+ plasmid in an antisense orientation (relative to
the SP6 promoter), producing the plasmid pCS2-XCEP2-
anti. In a similar fashion, an RNA expression vector con-
taining the XCEP2 insert in the sense orientation in pCS2+
was also constructed.
Capped mRNAs were synthesized in vitro using the mMes-
sage mMachine kit (SP6) from Ambion (Austin, TX), and
were dissolved in distilled water prior to injection.
Semi-quantitative RT-PCR
Total RNA was isolated from embryos using Trizol (Invit-
rogen) according to manufacturer's instructions. Reverse
transcription was carried out using SuperscriptIII (Invitro-
gen). Assessment of relative levels of gene expression over
developmental time, or under different experimental con-
ditions, was carried out using standard semi-quantitative
RT-PCR methods [43], with the primers previously
described (see RT-PCR Primers, above). 25 cycles of PCR
were carried out using Accuprime PCR mix (Invitrogen) in
25 ul reactions containing 2 ul of 200 ug/ml reverse tran-
scribed cDNA, 0.3µM of each primer, and a trace of radi-
olabelled nucleotide to allow for autoradiographic
visualization. Parallel reactions containing primers spe-
cific to the metabolic gene, ornithine decarboxylase
(ODC), were used as a loading control in all semi-quanti-
tative RT-PCR experiments. RT-PCR products were sepa-
rated electrophoretically on 5% acrylamide gels, which
were dried and subsequently subjected to autoradiogra-
phy. RT-PCR of the XCEP2A allele resulted in stronger
amplification than with the XCEP2B primer set. XCEP2B
bands required correspondingly longer exposure times
(2–4 fold) for detection.
Embryo manipulations
Adult  Xenopus laevis were purchased from Nasco (Fort
Atkinson, WI). Eggs were obtained and fertilized accord-
ing to standard methods. Staging was determined accord-
ing to Nieuwkoop and Faber [44]. Antisense morpholino
oligonucleotides and in vitro transcribed mRNA's were
injected into two-cell stage embryos, with injected vol-
umes of approximately 13 nl in doses as described. All
injections were carried out using the Nanoject positive
displacement microinjector (Drummond Scientific,
Broomall, PA).
Measurement of blastopore to embryo diameter ratios
was accomplished by dividing the measured blastopore
diameter (the distance between dorsal and ventral poles
of the blastopore) by the embryo diameter. Diameter
measurements were obtained using digital images of indi-
vidual embryos, and the "Ruler" tool of the Adobe Pho-
toshop software.
To assess the effects of morpholino antisense oligonucle-
otides on animal cap explants, morpholino injected and
control embryos were allowed to develop until stage 8.5.
At stage 8.5 animal caps were dissected, and then cultured
in 1xMMR for 24 hours. Non-dissected sibling embryos
were allowed to develop until post-neurula stages in order
to asses the effectiveness of the morpholino treatment.
Detection of myc-tagged protein expression
Proteins from embryos were extracted in 10 volumes of
isotonic buffered saline containing 1% NP40. Extracts
were cleared by a brief centrifugation, and supernatants
were denatured by a 5-minute incubation at 95°C after
diluting samples with SDS-PAGE sample buffer. Proteins
were separated on 8–16% gradient polyacrylamide gels,
and transferred to nitrocellulose. After blocking, blots
were probed with monoclonal antibody 9E10 [45], which
recognizes the myc epitope, and AP-conjugated goat-anti-
mouse IgG (Biorad, Hercules, CA). Antibody binding was
detected using Enhanced Chemiluminescence (ECL) rea-
gents (Amersham-Pharmacia, Piscataway, NJ). Equiva-
lency of protein loads was confirmed by running
equivalent volumes of protein extracts on SDS-PAGE, and
staining overnight with SYPRO Ruby (BioRad), with
detection and documentation of protein bands conducted
using UV transillumination.
Wholemount in situ hybridization
Digoxygenin-labelled antisense RNA probe was tran-
scribed in vitro from linearized pCS2-XCEP2anti plasmid
using a digoxygenin nucleotide labeling mix (Roche) and
the mMessage mMachine in vitro transcription kit (SP6)
from Ambion. In situ hybridization was carried out essen-
tially as described [46], using non-hydrolyzed X-CEP2
digoxygenin-labeled probe. Embryos were subjected to a
hybridization temperature of 62°C. AP-conjugated anti-
digoxygenin FAb fragments (Roche) and BM Purple sub-
strate (Roche) were used to detect hybridized probe.
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